alexa Abstract | Drug design, development and screening of pyrazolo pyridazine as potential agent for treatment of breast cancer

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


Pyrazolo pyridazine are obtained by diazotization of substituted anilines followed by coupling to form corresponding hydrazones which on Intramolecular cyclisation forms 3-acetyl- substituted-cinnolin-4-ones. Further, treatment with hydrazine hydrate yields the expected 3’-methyl-substituted-pyrazolo [4, 3-C] Cinnoline derivatives. The compounds were characterized by analytical techniques like TLC, UV, IR, NMR Spectral studies. All the synthesised compounds were checked for drug likeliness using QIKPROP software and found to be efficacious and Screening for anti-tumor activity against breast cancer cell lines. The compound 1C was found to be safe and potent drug moderately incomparison to standard drug.

To read the full article Peer-reviewed Article PDF image

Author(s): S Hurmath Unnissa and Shyaleen Rose


Pyrazolo pyridazine , Cinnoline, MCF-7 cell line, qikprop, Breast cancer, Drug design

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version